Novel Therapeutic Targets
Intrinsically disordered proteins (IDPs): disease drivers up to now considered intractable by the industry.
Proprietary Technology
Our Platform allows modulating the function of IDPs by retaining their inactive, disordered state.
Unmet Medical Needs
Breakthrough treatments for incurable diseases, including cancer and beyond.